China Drug Approvals | 2023 | NMPA Drug Approvals | Pharma | Healthcare | China | iPharmaCenter

China Drug Approvals | 2022 | NMPA Drug Approvals | Pharma | Healthcare | China | iPharmaCenter

China Healthcare News | Drug News | iPharmaCenter

Drug approvals in Japan | PMDA | MHLW Approvals | 2022 | 2023 | News | Media | Japan | iPharmaCenter

India | Healthcare News | Abbott to upgrade 75 PHCs | iPharmaCenter

Australia Healthcare News | Drug reimbursement

Australia Drug Approvals | Drugs approved by TGA

COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers

China released the 2022 NDRL list, Chinese pharma benefited from the list

Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief

WHO granted EUL to Covaxin; acclaims easy storage requirement

Levima received orphan designation from MHLW |Japan drug approvals | Japan Healthcare System

Expected best selling pharmaceutical products (drugs) in 2021

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

Bayer submitted vericiguat for market authorization in China

Bayer’s Xofigo received approval for prostate cancer in China

Merck’s Keytruda received one more indication and dosage form approval in Japan

AZ received one more approval in Japan, received approval of Imfinzi for SCLC

JAPAN HEALTHCARE SYSTEM